NSC
42
2
ICE
62
7
MNST
65
5
NFLX
59
-2
CCI
38
2
TGNA
56
3
ISRG
73
3
APA
32
2
NDAQ
49
7
NTAP
73
6
KR
55
2
COP
42
-3
PNR
63
3
AZO
46
-2
VMC
65
2
ADM
34
-2
RF
50
2
UNP
52
2
INTC
35
3
IP
40
4
NSC
42
2
ICE
62
7
MNST
65
5
NFLX
59
-2
CCI
38
2
TGNA
56
3
ISRG
73
3
APA
32
2
NDAQ
49
7
NTAP
73
6
KR
55
2
COP
42
-3
PNR
63
3
AZO
46
-2
VMC
65
2
ADM
34
-2
RF
50
2
UNP
52
2
INTC
35
3
IP
40
4
Financhill
Back

Omega Therapeutics 10K Form

Sell
46

OMGA
Omega Therapeutics

Last Price:
2.58
Seasonality Move:
-11.48%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OMGA News And Ratings

See the #1 stock for the next 7 days that we like better than OMGA

OMGA Financial Statistics

Sales & Book Value

Annual Sales: $3.09M
Cash Flow: $-18.2M
Price / Cash Flow: 0
Annual Sales: $1.05
Price / Book: 2.45

Profitability

EPS (TTM): -1.80000
Net Income (TTM): $-97.43M
Gross Margin: --
Return on Equity: -106.14%
Return on Assets: -51.09%

Omega Therapeutics Earnings Forecast

Key Omega Therapeutics Financial Ratios

  • The Research & Development expenses have been 2,494.15% of Revenue.
  • The Interest Expense is -1.33% of Operating Income.
  • The Net Earning history of OMGA is -3,148.93% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Omega Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: OMGA
Website: omegatherapeutics.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 3.35
Quick Ratio: 3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OMGA Technical Analysis vs Fundamental Analysis

Sell
46
Omega Therapeutics (OMGA) is a Sell

Is Omega Therapeutics a Buy or a Sell?